Skip to main content
Vivo Bio tech Ltd. logo

Vivo Bio tech Ltd. — Investor Relations & Filings

Ticker · 511509 ISIN · INE380K01017 LEI · 98450079E4M2CR80D882 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 440 across all filing types
Latest filing 2024-04-20 Regulatory Filings
Country IN India
Listing BSE.NS 511509

About Vivo Bio tech Ltd.

http://www.vivobio.com/

Vivo Bio Tech Ltd. is a preclinical Contract Research Organization (CRO) providing comprehensive drug discovery and development services. The company specializes in conducting in vivo preclinical studies, including toxicology, pharmacology, and pharmacokinetic evaluations. It operates advanced facilities for the breeding and distribution of Specific Pathogen Free (SPF) laboratory animal models, maintained through strategic partnerships with global leaders like Taconic Biosciences. Vivo Bio Tech offers regulatory-compliant services such as safety assessment, efficacy testing, and specialized research models to support pharmaceutical and biotechnology sectors. Its operations are characterized by adherence to Good Laboratory Practice (GLP) standards and AAALAC accreditation, ensuring high-quality data for global regulatory submissions.

Recent filings

Filing Released Lang Actions
we enclosed the information regarding the loss of share certificate(s) received from the shareholder(s) of the company on April 20, 2024 aggregating to 30 equity shares.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the loss of share certificates by shareholders. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions the issuance of a 'Letter of Confirmation' after compliance. The content is about shareholder administrative matters related to share certificates, not financial results, management changes, or capital structure updates. It is a regulatory compliance communication related to share certificate loss and does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. It is a regulatory filing informing the exchange about a specific shareholder issue, which fits best under Regulatory Filings (RNS). The document length is short and it is not an announcement of a report but a direct communication. Therefore, the classification is RNS with high confidence.
2024-04-20 English
In compliance with Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Certificate signed by the Company Secretary ....
Regulatory Filings
2024-04-13 English
Please find enclosed the certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, covering the period from January 1, 2024 to March 31, 2024. It is addressed to the stock exchange and confirms compliance actions related to dematerialization of securities. The document is short (2812 characters) and primarily serves as a compliance certificate rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or audit information. It is a regulatory compliance certificate related to securities and share transfer agent activities. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and certifications that do not fit other specific categories.
2024-04-11 English
please find enclosed the trading window closure notice
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the closure of the trading window in compliance with SEBI regulations related to insider trading. It mentions the trading window closure period around the declaration of audited financial results but does not contain any financial data or the results themselves. The document is an announcement related to regulatory compliance and trading restrictions, not a financial report or detailed filing. The length is only 1612 characters, indicating it is a brief notice. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-28 English
Please find enclosed the details of issue of confirmation letters
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) regarding the issuance of letters of confirmation for lost share certificates, pursuant to SEBI regulations. It details specific shareholder information and confirms the stop transfer against the shares. The document is short (2294 characters) and is an official notification related to share certificate replacement, not a financial report or detailed filing. It does not contain financial data, management discussion, or report content. This fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2024-03-28 English
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated ....
Regulatory Filings
2024-03-18 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.